Borg, D., Larsson, A. H., Hedner, C., Nodin, B., Johnsson, A., & Jirström, K. (2018). Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma. J Transl Med.
Style de citation ChicagoBorg, David, Anna H. Larsson, Charlotta Hedner, Björn Nodin, Anders Johnsson, et Karin Jirström. "Podocalyxin-like Protein As a Predictive Biomarker for Benefit of Neoadjuvant Chemotherapy in Resectable Gastric and Esophageal Adenocarcinoma." J Transl Med 2018.
Style de citation MLABorg, David, et al. "Podocalyxin-like Protein As a Predictive Biomarker for Benefit of Neoadjuvant Chemotherapy in Resectable Gastric and Esophageal Adenocarcinoma." J Transl Med 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.